[1]
|
Ewing J. (1972) Classics in Oncology. Diffuse Endothelioma of Bone. CA: A Cancer Journal for Clinicians, 22, 95-98.
https://doi.org/10.3322/canjclin.22.2.95
|
[2]
|
Grünewald, T.G.P., Cidre-Aranaz, F., Surdez, D., Tomazou, E.M., de Álava, E., Kovar, H., Sorensen, P.H., Delattre, O. and Dirksen, U. (2018) Ewing Sarcoma. Nature Reviews Disease Primers, 4, Article No. 5.
|
[3]
|
Gaspar, N., Hawkins, D.S., Dirksen, U., Lewis, I.J., Ferrari, S., Le Deley, M.C., et al. (2015) Ewing Sarcoma: Current Management and Future Approaches through Collaboration. Journal of Clinical Oncology, 33, 3036-3046.
https://doi.org/10.1200/JCO.2014.59.5256
|
[4]
|
Balamuth, N.J and Womer, R.B. (2010) Ewing’s Sarcoma. The Lancet Oncology, 11, 184-192.
https://doi.org/10.1016/S1470-2045(09)70286-4
|
[5]
|
(2018) Ewing Sarcoma. Nature Reviews Disease Primers, 4, Article No. 6. https://doi.org/10.1038/s41572-018-0007-6
|
[6]
|
刘杰, 赵田, 李钦传, 陈国涵. 肺癌免疫治疗进展[J/OL]. 中国胸心血管外科临床杂志: 1-9.
http://kns.cnki.net/kcms/detail/51.1492.r.20220126.1110.024.html, 2022-02-09.
|
[7]
|
de Aguiar Vallim, T.Q., Tarling, E.J. and Edwards, P.A. (2013) Pleiotropic Roles of Bile Acids in Metabolism. Cell Metabolism, 17, 657-669. https://doi.org/10.1016/j.cmet.2013.03.013
|
[8]
|
Lee, Y.J., Lee, E.Y., Choi, B.H., Jang, H., Myung, J.K. and You, H.J. (2020) The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability. Molecules and Cells, 43, 459-468.
|
[9]
|
Savola, S., Klami, A., Myllykangas, S., Manara, C., Manara, C., Scotlandi, K., et al. (2011) High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing’s Sarcoma Family of Tumour Patients. International Scholarly Research Notices, 2011, Article ID: 168712. https://doi.org/10.5402/2011/168712
|
[10]
|
Bailey, A.M., Zhan, L., Maru, D., Shureiqi, I., Pickering, C.R., Kiriakova, G., Izzo, J., He, N., Wei, C., Baladandayuthapani, V., Liang, H., Kopetz, S., Powis, G. and Guo, G.L. (2014) FXR Silencing in Human Colon Cancer by DNA Methylation and KRAS Signaling. American Journal of Physiology-Gastrointestinal and Liver, 306, G48-G58.
https://doi.org/10.1152/ajpgi.00234.2013
|
[11]
|
Jiang, L., Zhang, H., Xiao, D., Wei, H. and Chen, Y. (2021) Farnesoid X Receptor (FXR): Structures and Ligands. Computational and Structural Biotechnology Journal, 19, 2148-2159. https://doi.org/10.1016/j.csbj.2021.04.029
|
[12]
|
Volchenboum, S.L., Andrade, J., Huang, L., Barkauskas, D.A., Krailo, M., Womer, R.B., et al. (2015) Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children’s Oncology Group. The Journal of Pathology: Clinical Research, 1, 83-94.
https://doi.org/10.1002/cjp2.9
|
[13]
|
Yu, G., Wang, L.-G. Han, Y. and He, Q.-Y. (2012) clusterProfiler: An R Package for Comparingbiological Themes among Gene Clusters. OMICS: A Journal of Integrative Biology, 16, 284-287. https://doi.org/10.1089/omi.2011.0118
|
[14]
|
Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W. and Smyth, G.K. (2015). Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies. Nucleic Acids Research, 43, e47.
https://doi.org/10.1093/nar/gkv007
|
[15]
|
Newman, A.M., Liu, C.L., Green, M.R., Gentles, A.J., Feng, W., Xu, Y., Hoang, C.D., Diehn, M. and Alizadeh, A.A. (2015) Robust Enumeration of Cell Subsets from Tissue Expression Profiles. Nature Method, 12, 453-457.
https://doi.org/10.1038/nmeth.3337
|
[16]
|
Riggi, N., Suvà, M.L. and Stamenkovic, I. (2021) Ewing’s Sarcoma. New England Journal of Medicine, 384, 154-164.
https://doi.org/10.1056/NEJMra2028910
|
[17]
|
Eaton, B.R., Claude, L., Indelicato, D.J., Vatner, R., Yeh, B., Schwarz, R. and Laack, N. (2021) Ewing Sarcoma. Pediatric Blood & Cancer, 68, e28355. https://doi.org/10.1002/pbc.28355
|
[18]
|
Zöllner, S.K., Amatruda, J.F., Bauer, S., Collaud, S., de Álava, E., DuBois, S.G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., Shulman, D.S., Streitbürger, A., Timmermann, B., Toretsky, J.A., Uhlenbruch, Y., Vieth, V., Grünewald T.G.P. and Dirksen, U. (2021) Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. Journal of Clinical Medicine, 10, Article No. 1685. https://doi.org/10.3390/jcm10081685
|
[19]
|
Pappo, A.S. and Dirksen, U. (2018) Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas. Journal of Clinical Oncology, 36, 168-179. https://doi.org/10.1200/JCO.2017.74.7402
|
[20]
|
Morales, E., Olson, M., Iglesias, F., Dahiya, S., Luetkens, T. and Atanackovic, D. (2020) Role of Immunotherapy in Ewing Sarcoma. Journal for ImmunoTherapy of Cancer, 8, e000653.
https://doi.org/10.1136/jitc-2020-000653
|
[21]
|
Luo, C., Wei, J. and Han, W. (2016) Spotlight on Chimeric Antigen Receptor Engineered T Cell Research and Clinical Trials in China. Science China Life Sciences, 59, 349-359. https://doi.org/10.1007/s11427-016-5034-5
|